No data to display.

EXACT SCIENCES CORP posted revenue of 523,073

Published on Nov 04, 2022 | 05:34 AM IST

EXACT SCIENCES CORP [EXAS]

As of Nov 03, 2022| Source: Quarterly Report to the SEC

Exact Sciences Corporation (together with its subsidiaries, Exact, we, us, our or the Company) is a leading, global, advanced cancer diagnostics company. We have developed some of the most impactful tests in cancer diagnostics, and we are currently working to develop additional tests, with the goal of bringing new, innovative cancer tests to patients throughout the world.

Industry Services
Revenue 523,073
Profits -148761

Stock View